3 completed, 1 not yet recruiting, 1 unknown, 1 withdrawn. 2 Phase 3, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 4 | 2 | Completed 1, Withdrawn 1 |
Follow Mirabegron 25mg: new trials by email Literature Review of Mirabegron 25mg trials Research Report on Mirabegron 25mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial Mirabegron 25mg, Solifenacin 5 mg, Tolterodine 4 mg - Urinary Bladder, Overactive | Phase 3 | Not yet recruiting | Far Eastern Memorial Hospital | 220 | 2025-08-07 | 2025-08-11 |
| Predictors Affecting Long-term Use of Solifenacin or Mirabegron in Women With Overactive Bladder Syndrome Solifenacin Oral Tablet, Mirabegron 25mg - Overactive Bladder Syndrome | Unknown | Far Eastern Memorial Hospital | 500 | 2021-04-30 | 2023-03-29 | |
| Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Bladder Syndrome Mirabegron 25mg - Overactive Bladder Syndrome | Phase 4 | Withdrawn | Far Eastern Memorial Hospital | 2018-12-24 | 2019-03-07 | |
| Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive Bladder Mirabegron 25mg, Solifenacin Succinate 5 MG - Overactive Bladder | Phase 4 | Completed | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 81 | 2017-01-01 | 2018-06-19 |
| Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan Mirabegron 25mg - Urinary Incontinence, Overactive Bladder Syndrome | Phase 3 | Completed | Buddhist Tzu Chi General Hospital | 168 | 2015-04-28 | 2017-02-23 |
| Predictors for Retreatement of OAB After DC Mirabegron Mirabegron 25mg - Recurrence of Overactive Bladder Syndrome | Completed | National Taiwan University Hospital | 120 | 2015-01-01 | 2020-09-16 |
Urinary Bladder, Overactive (3) · Nocturia (1) · Urinary Incontinence (1)
Far Eastern Memorial Hospital (3) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Buddhist Tzu Chi General Hospital (1) · National Taiwan University Hospital (1)
Taiwan (4) · Bangladesh (1)
Hann-Chorng Kuo, MD (1) · Ho-Hsiung Lin, PhD (1)
PMID 19302497, PMID 19941278, PMID 25022469, PMID 25238744, PMID 27648660, PMID 29398096